Financhill
Back

ZyVersa Therapeutics Vs. Dermata Therapeutics Industry Stock Comparison

Sell
8

ZVSA
ZyVersa Therapeutics

Last Price:
1.12
Seasonality Move:
-77.19%
Sell
20

DRMA
Dermata Therapeutics

Last Price:
1.11
Seasonality Move:
-57.39%
Sell
8
ZyVersa Therapeutics (ZVSA) is a Sell

Is ZyVersa Therapeutics a Buy, Sell or Hold?

  • The current ZyVersa Therapeutics [ZVSA] share price is $1.14. The Score for ZVSA is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • ZVSA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Dermata Therapeutics (DRMA) is a Sell

Is Dermata Therapeutics a Buy, Sell or Hold?

  • The current Dermata Therapeutics [DRMA] share price is $1.15. The Score for DRMA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • DRMA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ZVSA Stock Price Chart

What is ZyVersa Therapeutics's stock price today?

  • The ZyVersa Therapeutics share price today is $1.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZVSA is experiencing slight selling pressure.

DRMA Stock Price Chart

What is Dermata Therapeutics's stock price today?

  • The Dermata Therapeutics share price today is $1.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing slight selling pressure.

ZVSA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 32.26 Sell
Chaikin Money Flow: -29814 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.26 - 2.16) Sell
Bollinger Bands (100): (1.77 - 3.65) Sell

DRMA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 39.31 Sell
Chaikin Money Flow: -22154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.17 - 1.47) Sell
Bollinger Bands (100): (1.3 - 2.18) Sell

ZVSA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.18 Sell
20-day SMA: 1.59 Sell
50-day SMA: 2 Sell
200-day SMA: 4.46 Sell
8-day EMA: 1.24 Sell
20-day EMA: 1.51 Sell
50-day EMA: 1.99 Sell
200-day EMA: 42.17 Sell

DRMA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.16 Sell
20-day SMA: 1.27 Sell
50-day SMA: 1.45 Sell
200-day SMA: 3.39 Sell
8-day EMA: 1.17 Sell
20-day EMA: 1.26 Sell
50-day EMA: 1.45 Sell
200-day EMA: 6.23 Sell

ZyVersa Therapeutics Earnings Growth & ZVSA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $698.82 per share, and an increase next year of $11.20 per share.

Dermata Therapeutics Earnings Growth & DRMA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ZyVersa Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dermata Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):